Araghi Contact us
Menu
Medisphere AXIn development · by Araghi

Post-market clinical evidence, captured at the point of care.

Medisphere AX is being built to help medical device manufacturers collect structured, consented and traceable feedback from surgeons after their devices are used. It is designed to support post-market surveillance and post-market clinical follow-up. Your records stay private to your company: you decide what is shared, and when.

Status: Medisphere AX is in development. We are looking for manufacturers to pilot it with us. It is data-collection software: it does not diagnose, treat or give clinical advice.

Medisphere AX

Why it matters

Post-market evidence is now a continuous duty.

Under the EU Medical Device Regulation, manufacturers must keep collecting clinical data on their devices after launch. Transition deadlines run to 31 December 2027 for Class III and most implantable Class IIb devices, and to 31 December 2028 for other Class IIb, Class IIa and some Class I devices.

Regulators increasingly accept evidence gathered in routine care. Medisphere AX is designed to help manufacturers build it case by case, so good ideas can reach patients sooner.

Sources: EU Medical Device Regulation (EU) 2017/745; US FDA guidance on using real-world evidence to support regulatory decisions for medical devices (December 2025). This is a summary for orientation only, not legal or regulatory advice.

For your team

Every team asks a different question.
One record, built to answer each.

Choosing software for medical devices is a shared decision. Choose your team to see what Medisphere AX is designed to give you.

Regulatory & quality

Evidence a notified body can follow.

What has changed

Post-market surveillance must now be proactive, specific to each device and fed back into risk management and clinical evaluation: under the EU MDR, and in Great Britain since June 2025. Gaps in clinical evidence are among the most common findings at notified body review.

Medisphere AX is designed to give you

Structured case records captured at the point of use, linked to device identifier, lot and expiry.

Records organised for PMCF, PSUR and clinical evaluation updates, with gaps shown, never filled in.

An evidence level and source on every record, so each conclusion traces back to the case.

One governed record that also answers the structured evidence hospital buyers increasingly request.

Want stronger clinical evidence for your next audit?

Book a call (opens Microsoft Bookings in a new tab)

Commercial

Make your device the easy one to justify.

What has changed

Hospital buyers are increasingly asked to justify their choices on value. Under national guidance published in June 2026, whole-life cost counts for at most 40% of a value-based procurement score for medical technology in England; the rest is weighted on value, and a national platform is in development that will let buyers compare products side by side on their evidence. Devices without structured, comparable evidence risk being passed over.

Medisphere AX is designed to give you

The product evaluations your field team already runs, turned into structured evidence, case by case.

Evidence you choose to share, approved by your medical and regulatory team, for value cases, tenders and evaluation committees.

Live sight of bookings, completed evaluations and coverage in every territory.

Designed to shorten the path from product evaluation to adoption.

Your field team sees process, never raw outcomes. Evidence reaches sales only once your medical and regulatory team approve it.

Want evidence that helps your device win on value?

Book a call (opens Microsoft Bookings in a new tab)

Medical affairs

Real-world insight, with the firewall built in.

The gap

Surgeon insight is the raw material of evidence strategy, yet it still reaches medical affairs through sales conversations and scattered notes, if it arrives at all.

Medisphere AX is designed to give you

Surgeon observations, including use outside the label, routed to your regulatory and medical review team only.

Structured outcome data, with confidence intervals and small numbers suppressed, to locate evidence gaps.

A foundation for studies, publications and the value dossiers buyers now expect.

Every view of an observation logged with who and why, so scientific exchange stays defensible.

Want surgeon feedback sent straight to your medical team?

Book a call (opens Microsoft Bookings in a new tab)

IT & security

Security by design.

The risk

Every new supplier is a new risk to assess: where the data lives, who can see it, and what happens when something goes wrong.

Medisphere AX is designed to give you

A separate workspace for each manufacturer, with every record marked and access set by role and purpose.

Every export, and every view of sensitive data, logged with a reason.

Multi-factor sign-in, and nothing for surgeons to install.

Independent penetration testing and health-sector security assessment planned before any real data.

Want to see exactly how your data is protected?

Book a call (opens Microsoft Bookings in a new tab)

Procurement

Value you can account for.

The cost

Post-market evidence has become one of the largest costs of keeping a device on the market, spread across surveys, studies, consultants and manual effort.

Medisphere AX is designed to give you

Evidence that builds up with every case, not a new study each time it is needed.

One system for regulatory, medical and commercial teams, in place of several tools and suppliers.

Your own records exportable as CSV and PDF, so your evidence stays yours, whatever happens.

Today, evidence often means a new survey or study each time it is needed. Medisphere AX is designed to collect it during normal work, so it is already there when someone asks. Formal clinical studies, where a device requires them, still apply.

Want evidence that builds up with every case?

Book a call (opens Microsoft Bookings in a new tab)

Emerging manufacturers

Where early use matters most.

Established manufacturers maintain registries and dedicated clinical affairs teams. Emerging innovators often rely on manual records, yet they have the most to learn from early use. Medisphere AX is designed to bring the same discipline to their first cases.

For an emerging device, use shapes the next design.

How it works

How a case becomes evidence.

  1. BookYour field team books the case before surgery. The time is locked and logged.
  2. ConsentWhere the survey needs it, the patient consents before the procedure, with each purpose ticked separately.
  3. CaptureThe surgeon answers directly, on their own phone, through a single-use link. No app, no login.
  4. Follow upFollow-ups run on a schedule set per procedure. Patient follow-up is on our roadmap.
  5. EvidenceEach case becomes a signed, traceable record your regulatory, quality and medical teams can review and export.

On any device. Medisphere AX is designed to run in the web browser on any smartphone, tablet, laptop or desktop, with nothing to install. Dedicated mobile apps for field teams are on our roadmap.

Concept film. Medisphere AX is in development and not yet commercially available.

What we say, and how we know

Every statement, with its basis beside it.

We show the status of each statement so you can judge it for yourself. We will update this table with results when we have them.

StatementStatusBasis
Surgeons complete the case review in under two minutesTargetTo be measured in a pilot.
Every case is time-stamped and every change is loggedDesign requirementTo be verified in an independent security review before any real data.
Evidence levels A, B and CDefinitionGrades how solid the process was for each case (booked before use, consent before the procedure). It is not a clinical score.
Observations beyond a product's label go only to regulatory and medical reviewDesign ruleNever shown to sales teams, never pooled, never used to promote.
One manufacturer can never see another's dataDesign requirementEnforced on the server and covered by automated tests.
Every booked case is counted, including cases that do not go aheadDesign ruleCases cannot be quietly dropped: withdrawals are recorded with a reason, and nothing is edited after the surgeon signs.
Outcomes are compared on a like-for-like basis (case mix)Design requirementEach case review can record relevant patient risk factors, such as anticoagulant therapy or a known bleeding disorder, so outcomes can be stratified by case mix.

Explore

Learn more about us.

Shape Medisphere AX with us.

We're looking for pilot partners of every size and device type: manufacturers, founders, distributors and clinical teams.

Contact us